Onur Gultekin, Nazim Haspolat, Bahar Cicek, Dieudonné Havyarimana, Ahmet Akici, Volkan Aydin
{"title":"Systematic review of survey/questionnaire-based drug utilization studies in Turkiye.","authors":"Onur Gultekin, Nazim Haspolat, Bahar Cicek, Dieudonné Havyarimana, Ahmet Akici, Volkan Aydin","doi":"10.14744/nci.2024.60252","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Drug utilization studies (DUS), providing insights into various aspects of pharmacoepidemiology from prescribing to medication use, can be conducted through real-world data from health records and survey-based data. In this study, we aimed to describe survey/questionnaire-based DUS conducted in Turkiye.</p><p><strong>Methods: </strong>We searched online databases for the most frequently used keywords in DUS from January 1993 till May 2023 and identified 180 survey-based DUS conducted in Turkiye. We described DUS by their populations, sociodemographic characteristics, timeframe, setting and provinces, data collection method, medication categories, and article-specific variables were evaluated.</p><p><strong>Results: </strong>We identified that 68.3% of the DUS were in English and 91.7% were indexed in Web of Science (median 1 [interquartile range: 1-2] citation). We found that 21.7% of the articles (n=39) had pharmacology affiliation. Adults are the target population in 37.8% of the studies and age and gender were not reported in 27.2% and 16.7%, respectively. The response rate was not stated in 55.0%. We determined that 48.3% of the studies were focused on a single medication/medication group. The mean time from data collection to publication was 2.5±1.9 years, and the highest number of articles (10.6%) were published in 2021.</p><p><strong>Conclusion: </strong>Our systematic review shows that the majority of DUS were listed in well-known international indices, suggesting that our local studies invoke global interest and hold a valuable position in health research. Nevertheless, lack of reporting of methodological characteristics in substantial part of the studies can be considered an important room for improvement of DUS.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 6","pages":"525-533"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622752/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Northern clinics of Istanbul","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/nci.2024.60252","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Drug utilization studies (DUS), providing insights into various aspects of pharmacoepidemiology from prescribing to medication use, can be conducted through real-world data from health records and survey-based data. In this study, we aimed to describe survey/questionnaire-based DUS conducted in Turkiye.
Methods: We searched online databases for the most frequently used keywords in DUS from January 1993 till May 2023 and identified 180 survey-based DUS conducted in Turkiye. We described DUS by their populations, sociodemographic characteristics, timeframe, setting and provinces, data collection method, medication categories, and article-specific variables were evaluated.
Results: We identified that 68.3% of the DUS were in English and 91.7% were indexed in Web of Science (median 1 [interquartile range: 1-2] citation). We found that 21.7% of the articles (n=39) had pharmacology affiliation. Adults are the target population in 37.8% of the studies and age and gender were not reported in 27.2% and 16.7%, respectively. The response rate was not stated in 55.0%. We determined that 48.3% of the studies were focused on a single medication/medication group. The mean time from data collection to publication was 2.5±1.9 years, and the highest number of articles (10.6%) were published in 2021.
Conclusion: Our systematic review shows that the majority of DUS were listed in well-known international indices, suggesting that our local studies invoke global interest and hold a valuable position in health research. Nevertheless, lack of reporting of methodological characteristics in substantial part of the studies can be considered an important room for improvement of DUS.
目的:药物利用研究(DUS)可以通过来自健康记录和基于调查的数据的真实数据进行,为从处方到药物使用的药物流行病学的各个方面提供见解。在本研究中,我们旨在描述在土耳其进行的基于调查/问卷的DUS。方法:检索1993年1月至2023年5月期间在线数据库中DUS使用频率最高的关键词,并对在土耳其进行的180例基于调查的DUS进行检索。我们对DUS的人群、社会人口统计学特征、时间框架、环境和省份、数据收集方法、药物类别和文章特定变量进行了评估。结果:我们发现68.3%的DUS为英文,91.7%的DUS被Web of Science收录(中位数为1[四分位数间距:1-2])。我们发现21.7%的文章(n=39)有药理学关联。37.8%的研究以成年人为目标人群,27.2%和16.7%的研究分别未报告年龄和性别。55.0%的回复率未注明。我们确定48.3%的研究集中于单一药物/药物组。从数据收集到发表的平均时间为2.5±1.9年,发表的文章数最多(10.6%)发生在2021年。结论:我们的系统综述显示,大多数DUS被列入国际知名指标,表明我们的本地研究引起了全球的关注,在卫生研究中具有重要的地位。然而,在大部分研究中缺乏方法特征的报告可以被认为是DUS改进的一个重要空间。